Oracle Corporation (NYSE:ORCL) closed at $134.47 on October 15, marking a 53.84% decline in its share price over the past twelve months. The decline contrasts sharply with the broader market, where the S&P 500 ETF returned 11.4% and the Insider Monkey Billionaire Index rose 15.4% during the same six‑month period.
Growth in revenue and earnings
Despite the steep price drop, Oracle reported robust growth in its most recent quarter. Revenue rose by almost one‑third year‑over‑year, while earnings grew at an even faster pace. The company’s traditional strength lies in database software, but it is increasingly selling the computing power that underpins other firms’ artificial‑intelligence initiatives. This newer, capital‑intensive segment is cited as a possible driver of the stock’s volatility.
Analyst confidence versus cash‑flow reality
Analyst sentiment remains broadly positive. Eighty percent of the analysts covering Oracle continue to rate the stock as a buy, and the median price target sits 78.48% above the current market price, according to CNN data. The optimism is largely anchored in Oracle’s sizable order backlog. The company has secured contracts to provide computing capacity far into the future, with commitments now totaling $638 billion—far exceeding its annual revenue, which is described as “a fraction” of that amount.
However, the financial statements reveal a stark contrast. Oracle’s cash‑flow statement shows $75.66 billion in capital expenditures over the past year, while cash generated from operations was $46.94 billion. The disparity indicates that the firm is spending considerably more than it is earning, a gap being financed through borrowing. This shift has altered Oracle’s balance sheet from its previous, less leveraged state.
Valuation metrics and market debate
Valuation ratios further illustrate the split view. The shares trade at 17.76 times the earnings analysts expect for next year and at 22.66 times the earnings reported for the past year. For a company posting rapid growth, these multiples are not unusually high, which adds to the puzzle of the depressed share price.
Investors and analysts appear to be pricing two different narratives. One side emphasizes the massive, long‑term contracts Oracle has secured, viewing them as a foundation for future revenue and profitability. The other side focuses on the immediate cash outflows required to fulfill those contracts, questioning whether the returns will materialize before the borrowing burden becomes problematic. Both perspectives rely on the same set of facts, but they prioritize different aspects of the company’s financial picture.
As Oracle continues to expand its AI‑computing infrastructure, the market will likely watch closely how the firm balances its ambitious capital spending with cash generation. The divergence between analyst optimism and the company’s current cash‑flow dynamics suggests that the stock’s future trajectory remains uncertain, even as a strong majority of analysts maintain a buy recommendation.
Norman Pearlstine is the Executive Editor and Co-Founder at News Raise. With over two decades of experience across financial journalism, corporate governance, and market analysis, Norman leads the editorial direction and ensures strict adherence to journalistic accuracy and ethics.
